Cargando…
The use of erlotinib in daily practice: a study on adherence and patients' experiences
BACKGROUND: Adherence to pharmacological therapy is a complex and multi-factorial issue that can substantially alter the outcome of treatment. It has been shown that cancer patients, especially when using long-term medication, have similar adherence rates to those of patients with other diseases. Th...
Autores principales: | Timmers, Lonneke, Boons, Christel CLM, Mangnus, Dirk, Moes, Josee E, Swart, Eleonora L, Boven, Epie, Smit, Egbert F, Hugtenburg, Jacqueline G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146940/ https://www.ncbi.nlm.nih.gov/pubmed/21722354 http://dx.doi.org/10.1186/1471-2407-11-284 |
Ejemplares similares
-
The use of capecitabine in daily practice: a study on adherence and patients’ experiences
por: Timmers, Lonneke, et al.
Publicado: (2012) -
Adherence, exposure and patients’ experiences with the use of erlotinib in non-small cell lung cancer
por: Timmers, Lonneke, et al.
Publicado: (2015) -
Study protocol of the RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia
por: Boons, Christel CLM, et al.
Publicado: (2014) -
Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice
por: Timmers, Lonneke, et al.
Publicado: (2016) -
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib
por: Boons, Christel C. L. M., et al.
Publicado: (2020)